This course equips healthcare professionals with practical strategies to reduce cardiovascular risk through evidence-based prevention and management. The modules cover recent developments in hypertension, diabetes and obesity management, while introducing innovative therapies such as SGLT-2 inhibitors and GLP-1 receptor agonists. Learners apply tools like the Framingham Risk Score to tailor interventions and explore approaches that address social determinants of health. By the end, clinicians gain actionable insights to optimize outcomes through multidisciplinary collaboration and patient-centered care.